TGF-B1 inhibition with losartan in combination with FOLFIRINOX (F-NOX) in locally advanced pancreatic cancer (LAPC): Preliminary feasibility and R0 resection rates from a prospective phase II study

被引：12
|
作者：
Murphy, Janet E.
Wo, Jennifer Yon-Li
Ferrone, Cristina
Jiang, Wenqing
Yeap, Beow Y.
Blaszkowsky, Lawrence Scott
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.386
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
386
引用
收藏
页数：1
相关论文
共 4 条
  • [1] Potentially curative combination of TGF-b1 inhibitor losartan and FOLFIRINOX (FFX) for locally advanced pancreatic cancer (LAPC): R0 resection rates and preliminary survival data from a prospective phase II study.
    Murphy, Janet E.
    Wo, Jennifer Yon-Li
    Ryan, David P.
    Jiang, Wenqing
    Yeap, Beow Y.
    Duda, Gabriel Dan
    Allen, Jill N.
    Blaszkowsky, Lawrence Scott
    Ferrone, Cristina
    Parikh, Aparna Raj
    Nipp, Ryan David
    Zhu, Andrew X.
    Goyal, Lipika
    Lillemoe, Keith D.
    DeLaney, Thomas F.
    Jain, Rakesh K.
    Clark, Jeffrey W.
    Boucher, Yves
    Fernandez-del Castillo, Carlos
    Hong, Theodore S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] FOLFIRINOX (F-NOX) followed by individualized radiation for borderline-resectable pancreatic cancer: Preliminary toxicity and R0 resection rates from a prospective phase II study.
    Murphy, Janet E.
    Wo, Jennifer Yon-Li
    Ryan, David P.
    Jiang, Wenqing
    Yeap, Beow Y.
    Blaszkowsky, Lawrence Scott
    Kwak, Eunice Lee
    Allen, Jill N.
    Clark, Jeffrey W.
    Faris, Jason Edward
    Zhu, Andrew X.
    Goyal, Lipika
    Mamon, Harvey J.
    Lillemoe, Keith D.
    DeLaney, Thomas F.
    Castillo, Carlos Fernandez-del
    Ferrone, Cristina
    Hong, Theodore S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [3] FOLFIRINOX (F-NOX) followed by individualized radiation for borderline-resectable pancreatic cancer (BRPC): Toxicity, RO resection, and interim survival data from a prospective phase II study.
    Murphy, Janet E.
    Wo, Jennifer Yon-Li
    Ryan, David P.
    Jiang, Wenqing
    Yeap, Beow Y.
    Drapek, Lorraine C.
    Blaszkowsky, Lawrence Scott
    Kwak, Eunice Lee
    Allen, Jill N.
    Clark, Jeffrey W.
    Faris, Jason Edward
    Zhu, Andrew X.
    Goyal, Lipika
    Mamon, Harvey J.
    Wolpin, Brian M.
    Lillemoe, Keith D.
    DeLaney, Thomas F.
    Fernandez-del Castillo, Carlos
    Ferrone, Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] A multicenter randomized phase II study of NPC-1C (N) in combination with gemcitabine (G) and nab-paclitaxel (A) versus G and A alone in patients with metastatic or locally advanced pancreatic cancer (PC) previously treated with folfirinox (F)
    Duffy, Austin G.
    Beg, Muhammad Shaalan
    Greten, Tim F.
    Beatson, Melony A.
    Mavroukakis, Sharon
    Patel, Sandip Pravin
    Morse, Michael A.
    Arlen, Philip M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
1